Literature DB >> 29938237

Awareness and knowledge about cervical cancer prevention methods among Tunisian women.

R Gamaoun1.   

Abstract

INTRODUCTION: Epidemiological and biological arguments put papillomavirus infection (HPV) as a determining factor in the etiology of cervical cancer. The main objective of this study is to assess the knowledge, attitudes and practices related to HPV prevention and cervical cancer screening among women living in the city of Sousse, Tunisia.
METHODS: Five hundred Tunisian women were interviewed face to face between May and June 2016. The questionnaire consisted in 14 questions relating participants' socio-demographic information, their awareness level, attitudes and practices regarding HPV and cervical cancer, including their understanding of the underlying cervical cancer etiology and preventive actions such as the Pap Smear test, and finally their acceptability and willingness to receive the anti-HPV vaccine under certain circumstances. Multivariate analyses were conducted to identify predictive factors of good acceptability of cervical cancer prevention methods.
RESULTS: Four hundred fifty-two questionnaires were completed and included in the analysis. The awareness of a sexually transmitted infection as an etiological agent for cervical cancer was expressed by 175 (38.7%) participants, the correct finality of the Pap Smear test by 308 (68%) and its recommended frequency by 176 (38.9%) respondents. Among all participants, 125 (27.7%) had undertaken the Pap Smear test at least once in their lifetime, 363 (80.3%) were interested in receiving the anti-HPV vaccine for themselves, 387 (86%) for their daughters and 405 (90%) approved the introduction of the anti-HPV vaccine in the Tunisian national program of vaccination.
CONCLUSIONS: The knowledge and awareness of HPV infection and cervical cancer among Tunisian women was found to be moderate (around 40%) and the acceptability of the anti-HPV vaccine was found to be high (over 80%). These results are concordant with the results of other studies conducted in other MENA countries.

Entities:  

Keywords:  Anti-HPV vaccine; Cervical cancer prevention; Tunisia; Women

Mesh:

Year:  2018        PMID: 29938237      PMCID: PMC6009070          DOI: 10.15167/2421-4248/jpmh2018.59.1.709

Source DB:  PubMed          Journal:  J Prev Med Hyg        ISSN: 1121-2233


  14 in total

Review 1.  Sexuality and sexual health: constructs and expressions in the extended Middle East and North Africa.

Authors:  Faysal El-Kak
Journal:  Vaccine       Date:  2013-12-30       Impact factor: 3.641

2.  Human papillomavirus vaccination uptake and factors related to uptake in a traditional desert city in the United Arab Emirates.

Authors:  N S Al-Nuaimi; Y S Al-Ghas; A H Al-Owais; M Grivna; J Schneider; N J Nagelkerke; R M Bernsen
Journal:  Int J STD AIDS       Date:  2011-07       Impact factor: 1.359

Review 3.  Burden of human papillomavirus infections and related diseases in the extended Middle East and North Africa region.

Authors:  Salvatore Vaccarella; Laia Bruni; Muhieddine Seoud
Journal:  Vaccine       Date:  2013-12-30       Impact factor: 3.641

4.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.

Authors:  Jacques Ferlay; Hai-Rim Shin; Freddie Bray; David Forman; Colin Mathers; Donald Maxwell Parkin
Journal:  Int J Cancer       Date:  2010-12-15       Impact factor: 7.396

5.  Prevalence and type distribution of human papillomavirus among women older than 18 years in Egypt: a multicenter, observational study.

Authors:  Mohamed Fadel Shaltout; Hassan N Sallam; Maged AbouSeeda; Fady Moiety; Hossam Hemeda; Ahmed Ibrahim; Moutaz E L Sherbini; Helmy Rady; Kusuma Gopala; Rodrigo DeAntonio
Journal:  Int J Infect Dis       Date:  2014-11-01       Impact factor: 3.623

6.  Acceptability of the human papilloma virus vaccine among Moroccan parents: a population-based crosssectional study.

Authors:  F Selmouni; A Zidouh; C Nejjari; R Bekkali
Journal:  East Mediterr Health J       Date:  2015-09-28       Impact factor: 1.628

7.  Human papillomavirus infection in women with and without cervical cancer in Tehran, Iran.

Authors:  Nahid Khodakarami; Gary M Clifford; Parvin Yavari; Farah Farzaneh; Saghar Salehpour; Natalie Broutet; Heli Bathija; Daniëlle A M Heideman; Folkert J van Kemenade; Chris J L M Meijer; Seyed Jalil Hosseini; Silvia Franceschi
Journal:  Int J Cancer       Date:  2011-11-30       Impact factor: 7.396

8.  An epidemiological study assessing the prevalence of human papillomavirus types in women in the Kingdom of Bahrain.

Authors:  Khairya Moosa; Adel Salman Alsayyad; Wim Quint; Kusuma Gopala; Rodrigo DeAntonio
Journal:  BMC Cancer       Date:  2014-12-03       Impact factor: 4.430

9.  Cervical cancer and HPV: Awareness and vaccine acceptability among parents in Morocco.

Authors:  Mustapha Mouallif; Harriet L Bowyer; Soukaina Festali; Adelin Albert; Younes Filali-Zegzouti; Samuel Guenin; Philippe Delvenne; Jo Waller; Moulay Mustapha Ennaji
Journal:  Vaccine       Date:  2013-11-01       Impact factor: 3.641

10.  Knowledge about HPV, relation between HPV and cervix cancer and acceptance of HPV vaccine in women in eastern region of Turkey.

Authors:  Esra Tonguc; Tayfun Gungor; Turgut Var; Ebru Kavak; Munihe Yucel; Ozlem Uzunlar
Journal:  J Gynecol Oncol       Date:  2013-01-08       Impact factor: 4.401

View more
  3 in total

1.  Palliative interventions for controlling vaginal bleeding in advanced cervical cancer.

Authors:  George U Eleje; Ahizechukwu C Eke; Gabriel O Igberase; Anthony O Igwegbe; Lydia I Eleje
Journal:  Cochrane Database Syst Rev       Date:  2019-03-19

2.  Awareness of human papillomavirus and acceptability of the vaccine among women in Palestine: is it time for policy adjustment?

Authors:  Mohamedraed Elshami; Hanan Abukmail; Nasser Abu-El-Noor; Bettina Bottcher; Ibrahim Al-Slaibi; Mohammed Alser; Afnan Radaydeh; Alaa Alfuqaha; Mariam Thalji; Salma Khader; Lana Khatib; Nour Fannoun; Bisan Ahmad; Lina Kassab; Hiba Khrishi; Deniz Houssaini; Nour Abed; Aya Nammari; Tumodir Abdallah; Zaina Alqudwa; Shahd Idais; Ghaid Tanbouz; Ma'alem Hajajreh; Hala Abu Selmiyh; Zakia Abo-Hajouj; Haya Hebi; Manar Zamel; Refqa Najeeb Skaik; Lama Hammoud; Saba Rjoub; Hadeel Ayesh; Toqa Rjoub; Rawan Zakout; Amany Alser
Journal:  BMC Womens Health       Date:  2022-08-19       Impact factor: 2.742

3.  Human Papillomavirus Knowledge and Vaccine Acceptability in Jazan Province, Saudi Arabia.

Authors:  Atheer I Darraj; Alshaymaa M Arishy; Atheer H Alshamakhi; Njoud A Osaysi; Shatha M Jaafari; Shareefa A Sumayli; Rawiah Y Mushari; Abdulaziz H Alhazmi
Journal:  Vaccines (Basel)       Date:  2022-08-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.